Literature DB >> 31152339

Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C.

Josef Finsterer1, Franco Laccone2.   

Abstract

OPA1 variants most frequently manifest phenotypically with pure autosomal dominant optic atrophy (ADOA) or with ADOA plus. The most frequent abnormalities in ADOA plus in addition to the optic nerve affection include hypoacusis, migraine, myopathy, and neuropathy. Hypertelorism and atrophy of the acoustic nerve have not been reported. The patient is a 48yo Caucasian female with slowly progressive, visual impairment since childhood, bilateral hypoacusis since age 10y, and classical migraine since age 20y. The family history was positive for diabetes (father, mother) and visual impairment (daughter). Clinical examination revealed hypertelorism, visual impairment, hypoacusis, tinnitus, weakness for elbow flexion and finger straddling, and generally reduced tendon reflexes. MRI of the cerebrum was non-informative but hypoplasia of the acoustic nerve bilaterally was described. Visually-evoked potentials revealed markedly prolonged P100-latencies bilaterally. Acoustically-evoked potentials were distorted with poor reproducibility and prolonged latencies. Muscle biopsy revealed reduced activities of complexes I, II, and IV. Genetic work-up revealed the novel variant c.1463G>C in the OPA1 gene. This case provides novel information regarding the genotype of ADOA plus. The novel OPA1 variant c.1463G>C not only manifests with visual impairment, hypoacusis, migraine, and myopathy, but also with hypertelorisms and acoustic nerve atrophy.

Entities:  

Keywords:  Hypoacusis; Migraine; Multiple mtDNA deletions; Mutation; Optic atrophy; Retinal ganglion cells

Mesh:

Substances:

Year:  2019        PMID: 31152339     DOI: 10.1007/s11011-019-00425-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.

Authors:  E Pretegiani; F Rosini; A Rufa; G N Gallus; E Cardaioli; P Da Pozzo; S Bianchi; V Serchi; M Collura; R Franceschini; S Bianchi Marzoli; M T Dotti; A Federico
Journal:  J Neurol Sci       Date:  2017-09-14       Impact factor: 3.181

2.  A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.

Authors:  K E Ahmad; R L Davis; C M Sue
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

3.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

Review 4.  Mitochondrial disorders of the retinal ganglion cells and the optic nerve.

Authors:  Josef Finsterer; Michelangelo Mancuso; Davide Pareyson; Jean-Marc Burgunder; Thomas Klopstock
Journal:  Mitochondrion       Date:  2017-10-18       Impact factor: 4.160

5.  Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.

Authors:  Michelle Ham; Julia Han; Kathryn Osann; Moyra Smith; Virginia Kimonis
Journal:  Mitochondrion       Date:  2018-08-27       Impact factor: 4.160

6.  Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission.

Authors:  Sylvie Gerber; Majida Charif; Jean-Michel Rozet; Guy Lenaers; Arnaud Chevrollier; Tanguy Chaumette; Claire Angebault; Mariame Selma Kane; Aurélien Paris; Jennifer Alban; Mélanie Quiles; Cécile Delettre; Dominique Bonneau; Vincent Procaccio; Patrizia Amati-Bonneau; Pascal Reynier; Stéphanie Leruez; Raphael Calmon; Nathalie Boddaert; Benoit Funalot; Marlène Rio; Didier Bouccara; Isabelle Meunier; Hiromi Sesaki; Josseline Kaplan; Christian P Hamel
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

7.  OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation.

Authors:  Rosamaria Santarelli; Roberta Rossi; Pietro Scimemi; Elona Cama; Maria Lucia Valentino; Chiara La Morgia; Leonardo Caporali; Rocco Liguori; Vincenzo Magnavita; Anna Monteleone; Ariella Biscaro; Edoardo Arslan; Valerio Carelli
Journal:  Brain       Date:  2015-01-05       Impact factor: 13.501

8.  Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.

Authors:  Alessia Nasca; Teresa Rizza; Mara Doimo; Andrea Legati; Andrea Ciolfi; Daria Diodato; Cristina Calderan; Gianfranco Carrara; Eleonora Lamantea; Chiara Aiello; Michela Di Nottia; Marcello Niceta; Costanza Lamperti; Anna Ardissone; Stefania Bianchi-Marzoli; Giancarlo Iarossi; Enrico Bertini; Isabella Moroni; Marco Tartaglia; Leonardo Salviati; Rosalba Carrozzo; Daniele Ghezzi
Journal:  Orphanet J Rare Dis       Date:  2017-05-12       Impact factor: 4.123

9.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.

Authors:  Patrizia Amati-Bonneau; Maria Lucia Valentino; Pascal Reynier; Maria Esther Gallardo; Belén Bornstein; Anne Boissière; Yolanda Campos; Henry Rivera; Jesús González de la Aleja; Rosanna Carroccia; Luisa Iommarini; Pierre Labauge; Dominique Figarella-Branger; Pascale Marcorelles; Alain Furby; Katell Beauvais; Franck Letournel; Rocco Liguori; Chiara La Morgia; Pasquale Montagna; Maria Liguori; Claudia Zanna; Michela Rugolo; Andrea Cossarizza; Bernd Wissinger; Christophe Verny; Robert Schwarzenbacher; Miguel Angel Martín; Joaquín Arenas; Carmen Ayuso; Rafael Garesse; Guy Lenaers; Dominique Bonneau; Valerio Carelli
Journal:  Brain       Date:  2007-12-24       Impact factor: 13.501

10.  Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation.

Authors:  Ronen Spiegel; Ann Saada; Padraig J Flannery; Florence Burté; Devorah Soiferman; Morad Khayat; Verónica Eisner; Eugene Vladovski; Robert W Taylor; Laurence A Bindoff; Avraham Shaag; Hanna Mandel; Ora Schuler-Furman; Stavit A Shalev; Orly Elpeleg; Patrick Yu-Wai-Man
Journal:  J Med Genet       Date:  2015-11-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.